These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 21148255

  • 21. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S, Park E, Min SI, Yi NJ, Ha J, Ha IS, Cheong HI, Kang HG.
    J Korean Med Sci; 2018 Jan 01; 33(1):e4. PubMed ID: 29215813
    [Abstract] [Full Text] [Related]

  • 22. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M, Go RS, Willrich MAV.
    J Immunol Methods; 2018 Oct 01; 461():15-22. PubMed ID: 30031798
    [Abstract] [Full Text] [Related]

  • 23. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F.
    Pediatr Nephrol; 2013 Jan 01; 28(1):155-8. PubMed ID: 22956028
    [Abstract] [Full Text] [Related]

  • 24. Atypical hemolytic uremic syndrome.
    Loirat C, Frémeaux-Bacchi V.
    Orphanet J Rare Dis; 2011 Sep 08; 6():60. PubMed ID: 21902819
    [Abstract] [Full Text] [Related]

  • 25. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group.
    Clin J Am Soc Nephrol; 2013 Mar 08; 8(3):407-15. PubMed ID: 23243267
    [Abstract] [Full Text] [Related]

  • 26. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct 08; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 27. Antibody recognition of complement factor H reveals a flexible loop involved in atypical hemolytic uremic syndrome pathogenesis.
    Yokoo T, Tanabe A, Yoshida Y, Caaveiro JMM, Nakakido M, Ikeda Y, Fujimura Y, Matsumoto M, Entzminger K, Maruyama T, Okumura CJ, Nangaku M, Tsumoto K.
    J Biol Chem; 2022 Jun 08; 298(6):101962. PubMed ID: 35452676
    [Abstract] [Full Text] [Related]

  • 28. Anti-complement factor H (CFH) antibodies and a novel CFH gene mutation in an atypical hemolytic uremic syndrome patient with complement activation of the classical pathway.
    Minato S, Iijima H, Nakao H, Nishi K, Hidaka Y, Inoue N, Kubota M, Ishiguro A.
    Immunol Med; 2021 Dec 08; 44(4):274-277. PubMed ID: 33784485
    [Abstract] [Full Text] [Related]

  • 29. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication.
    Tasaki Y, Tsujimoto H, Yokoyama T, Sugimoto N, Kitajima S, Fujii H, Hidaka Y, Kato N, Maruyama S, Inoue N, Wada T.
    Front Immunol; 2024 Dec 08; 15():1360855. PubMed ID: 38524137
    [Abstract] [Full Text] [Related]

  • 30. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
    Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, Bresin E, Remuzzi G, Rodriguez de Cordoba S, Noris M.
    J Am Soc Nephrol; 2015 Jan 08; 26(1):209-19. PubMed ID: 24904082
    [Abstract] [Full Text] [Related]

  • 31. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A, Reuter S, Trojnár E, Kolodziejczyk R, Seeberger H, Hyvärinen S, Uzonyi B, Szilágyi Á, Prohászka Z, Goldman A, Józsi M, Jokiranta TS.
    J Biol Chem; 2015 Apr 10; 290(15):9500-10. PubMed ID: 25659429
    [Abstract] [Full Text] [Related]

  • 32. [Comparative characteristics of the complement system in patients with C3-glomerulopathy and atypical hemolytic uremic syndrome of chronic course who suffered an acute episode of thrombotic microangiopathy].
    Yurova VA, Kozlovskaya NL, Bobrova LA, Kozlov LV, Andina SS, Demyanova KA.
    Ter Arkh; 2023 Aug 17; 95(6):475-480. PubMed ID: 38158966
    [Abstract] [Full Text] [Related]

  • 33. Atypical hemolytic uremic syndrome due to factor H autoantibody.
    Uslu-Gökceoğlu A, Doğan CS, Comak E, Koyun M, Akman S.
    Turk J Pediatr; 2013 Aug 17; 55(1):86-9. PubMed ID: 23692839
    [Abstract] [Full Text] [Related]

  • 34. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M, European Working Party on Complement Genetics in Renal Diseases.
    J Am Soc Nephrol; 2013 Feb 17; 24(3):475-86. PubMed ID: 23431077
    [Abstract] [Full Text] [Related]

  • 35. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE, Abarrategui-Garrido C, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship TH, López Trascasa M, Noris M, Ponce Castro IM, Remuzzi G, Rodríguez de Córdoba S, Sánchez-Corral P, Skerka C, Zipfel PF, Perkins SJ.
    Hum Mutat; 2007 Mar 17; 28(3):222-34. PubMed ID: 17089378
    [Abstract] [Full Text] [Related]

  • 36. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H, Chaudhuri A, Concepcion W, Grimm PC.
    Pediatr Nephrol; 2014 Mar 17; 29(3):477-80. PubMed ID: 24221349
    [Abstract] [Full Text] [Related]

  • 37. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K, Seeman T.
    Transplant Proc; 2018 Apr 17; 50(3):967-970. PubMed ID: 29661469
    [Abstract] [Full Text] [Related]

  • 38. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.
    Sugawara Y, Kato H, Nagasaki M, Yoshida Y, Fujisawa M, Minegishi N, Yamamoto M, Nangaku M.
    J Hum Genet; 2023 Jun 17; 68(6):427-430. PubMed ID: 36755127
    [Abstract] [Full Text] [Related]

  • 39. Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report.
    Rysava R, Peiskerova M, Tesar V, Benes J, Kment M, Szilágyi Á, Csuka D, Prohászka Z.
    Front Immunol; 2022 Jun 17; 13():1001366. PubMed ID: 36275662
    [Abstract] [Full Text] [Related]

  • 40. Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.
    Gonzales E, Ulinski T, Habes D, Deschênes G, Frémeaux-Bacchi V, Bensman A.
    Pediatr Nephrol; 2016 Dec 17; 31(12):2375-2378. PubMed ID: 27744619
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.